DaShenLin Pharmaceutical Group Co Ltd banner
D

DaShenLin Pharmaceutical Group Co Ltd
SSE:603233

Watchlist Manager
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
Watchlist
Price: 19.25 CNY Market Closed
Market Cap: ¥21.9B

Wall St Price Targets

Price Targets Summary
DaShenLin Pharmaceutical Group Co Ltd

Wall Street analysts forecast DaShenLin Pharmaceutical Group Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DaShenLin Pharmaceutical Group Co Ltd is 25.22 CNY with a low forecast of 23.23 CNY and a high forecast of 28.04 CNY.

Lowest Forecast
Price Target
23.23 CNY
21% Upside
Average Forecast
Price Target
25.22 CNY
31% Upside
Highest Forecast
Price Target
28.04 CNY
46% Upside
DaShenLin Pharmaceutical Group Co Ltd Competitors:
Price Targets
ARTO
Bank Jago Tbk PT
45% Upside

Revenue
Forecast

18% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
18% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 10 years, the compound annual growth rate for Revenue has been 18%. The projected CAGR for the next 3 years is 9%.

Gross Profit
Forecast

16% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat
16% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat

Over the last 10 years, the compound annual growth rate for Gross Profit has been 16%. The projected CAGR for the next 2 years is 10%.

Operating Income
Forecast

13% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
13% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Over the last 10 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 3 years is 17%.

Pre-Tax Income
Forecast

13% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
13% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Over the last 10 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 2 years is 14%.

Net Income
Forecast

12% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
12% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Over the last 10 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 2 years is 16%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is DaShenLin Pharmaceutical Group Co Ltd's stock price target?
Price Target
25.22 CNY

According to Wall Street analysts, the average 1-year price target for DaShenLin Pharmaceutical Group Co Ltd is 25.22 CNY with a low forecast of 23.23 CNY and a high forecast of 28.04 CNY.

What is the Revenue forecast for DaShenLin Pharmaceutical Group Co Ltd?
Projected CAGR
9%

Over the last 10 years, the compound annual growth rate for Revenue has been 18%. The projected CAGR for the next 3 years is 9%.

What is the Gross Profit forecast for DaShenLin Pharmaceutical Group Co Ltd?
Projected CAGR
10%

Over the last 10 years, the compound annual growth rate for Gross Profit has been 16%. The projected CAGR for the next 2 years is 10%.

What is the Operating Income forecast for DaShenLin Pharmaceutical Group Co Ltd?
Projected CAGR
17%

Over the last 10 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 3 years is 17%.

What is the Pre-Tax Income forecast for DaShenLin Pharmaceutical Group Co Ltd?
Projected CAGR
14%

Over the last 10 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 2 years is 14%.

What is the Net Income forecast for DaShenLin Pharmaceutical Group Co Ltd?
Projected CAGR
16%

Over the last 10 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 2 years is 16%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett